This is an old revision of this page, as edited by C.Fred (talk | contribs) at 20:23, 24 February 2013 (Undid revision 540128279 by Bekacko (talk) - good faith, but WP is not a dictionary). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 20:23, 24 February 2013 by C.Fred (talk | contribs) (Undid revision 540128279 by Bekacko (talk) - good faith, but WP is not a dictionary)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) | This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Kank-A" – news · newspapers · books · scholar · JSTOR (July 2009) (Learn how and when to remove this message) |
Kank-A is a liquid pharmaceutical product marketed by Blistex used primarily to treat canker sores. It is applied directly on the sore and works by numbing the local area (with benzocaine) to prevent discomfort and forming a protective mucous barrier with a compound benzoin tincture that protects the ulcer from further irritation, allowing it to heal more rapidly.
 | This product article is a stub. You can help Misplaced Pages by expanding it. |